Skip to main content
Clinical Trials/NCT06051383
NCT06051383
Completed
N/A

Building Patient Capability for Managing Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Amna A. Desouky, MD1 site in 1 country60 target enrollmentJune 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Benign Prostatic Hyperplasia
Sponsor
Amna A. Desouky, MD
Enrollment
60
Locations
1
Primary Endpoint
Severity of lower urinary tract symptoms of benign prostate hyperplasia.
Status
Completed
Last Updated
last year

Overview

Brief Summary

Aim of this study is to evaluate the effect of conducting self-management interventions on severity of lower urinary tract symptoms (LUTS) for patients with benign prostatic hyperplasia (BPH).

Research hypothesis:

To fulfill the aim of this study, the following research hypothesis was formulated:

Patients with benign prostatic hyperplasia will suffer less lower urinary tract symptoms (LUTS) after conducting self-management intervention than before conducting.

Detailed Description

Research design: Quasi-experimental (pre-posttest) research design was utilized to conduct this study. This study was conducted at Assiut Urology and Nephrology Hospital. A purposive sample of 60 adult male patients diagnosed with benign prostatic hyperplasia were older than 40 years old, had no other factors influencing their urination, such as prostate cancer. Patients had been assessed at base line using the following tools: Tool (I): A structured interview questionnaire. Tool (II): International Prostate Symptom Score (IPSS). Each patient will be assessed before conducting self-management intervention for socio-demographic data, clinical data, and patients' knowledge regarding self-management using the tool I. Each patient will be assessed for lower urinary tract symptoms before conducting self-management intervention using tool tool II(IPSS). IPSS is a scoring system used to screen for and diagnose BPH as well as to monitor symptoms and guide decisions about how to manage the disease monitor lower urinary tract symptoms, It includes seven questions, about symptom of BPH.Each question had a range from 0 to 5 for its answer. Maximum score of 35 points. On the basis of total score, the symptoms were categorized into mild (0 -7), moderate (8-19), and severe (20-35). After 3 months from conducting self-management intervention each patient was reassessed for clinical progression "severity" of lower urinary tract symptoms(LUTS)using (tools II).

Registry
clinicaltrials.gov
Start Date
June 1, 2023
End Date
July 1, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
Male

Investigators

Sponsor
Amna A. Desouky, MD
Responsible Party
Sponsor Investigator
Principal Investigator

Amna A. Desouky, MD

Assistant Professor of Medical Surgical Nursing

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Severity of lower urinary tract symptoms of benign prostate hyperplasia.

Time Frame: Three months

Evaluate outcome of conducting self-management intervention sessions on clinical progression of lower urinary tract symptoms of benign prostate hyperplasia. through assessing Lower urinary tract symptoms of benign prostate hyperplasia before and after self-management intervention by using international prostate symptom score (IPSS) The IPSS was developed by American Urological Association, 1992. Is a scoring system used to screen for and diagnose BPH as well as to monitor symptoms and guide decisions about how to manage the disease, It includes seven questions, about symptom of BPH that asked to the patients about how often they have. Each question had a range 5 from 0 to 5 for its answer. Maximum score of 35 points. On the basis of total score, the symptoms were categorized into mild (0 -7), moderate (8-19), and severe (20-35).

Study Sites (1)

Loading locations...

Similar Trials